Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Selectin-mediated cell adhesion is a critical process involving the interaction between selectins (E-, P-, and L-selectin) and their carbohydrate ligands, primarily PSGL-1, on leukocytes and endothelial cells. This interaction initiates leukocyte rolling and adhesion to the endothelium, which is essential for immune surveillance, inflammation, and also contributes to thrombosis and cancer metastasis. Targeting selectins or their ligands offers therapeutic potential for treating inflammatory diseases and preventing cancer spread.
Inhibition of selectin-ligand binding, blocking leukocyte rolling and adhesion to the endothelium.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selectin-Mediated Cell Adhesion (N/A).